Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Pieter Neels"'
Autor:
Susanna Kharit, Dmitry Lioznov, Michail Kostinov, Ronald Kompier, Tim Hardman, Walter Beyer, Pieter Neels
Publikováno v:
F1000Research, Vol 11 (2022)
A systematic review of clinical trials conducted with a low-dose inactivated influenza vaccine adjuvanted by azoximer bromide (AZB, Polyoxidonium), was performed to compare vaccine reactogenicity against non-adjuvant vaccines. We also assessed whethe
Externí odkaz:
https://doaj.org/article/72af1419067b4976b2d3992abda0462d
Autor:
Susanna Kharit, Dmitry Lioznov, Michail Kostinov, Ronald Kompier, Tim Hardman, Walter Beyer, Pieter Neels
Publikováno v:
F1000Research, Vol 11 (2022)
A systematic review of clinical trials conducted with a low-dose inactivated influenza vaccine adjuvanted by azoximer bromide (AZB, Polyoxidonium), was performed to compare vaccine reactogenicity against non-adjuvant vaccines. We also assessed whethe
Externí odkaz:
https://doaj.org/article/16145027936a445b8a6e2a8d2a56a0c1
Autor:
Marc Baay, Pieter Neels
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/f5f9c19181ac49b5b6603be12f2ec935
Autor:
Ulrich Kalinke, Dan H. Barouch, Ruben Rizzi, Eleni Lagkadinou, Özlem Türeci, Shanti Pather, Pieter Neels
Publikováno v:
Expert Review of Vaccines. 21:609-619
The coronavirus 19 (COVID-19) pandemic triggered a simultaneous global demand for preventative vaccines, which quickly became a high priority among governments as well as academia and the pharmaceutical industry. Within less than a year after COVID-1
Autor:
Pieter Neels, Marc Baay
Publikováno v:
Biologicals
This second International Alliance for Biological Standardization COVID-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable participation from low- and mid
Autor:
Robert A Johnson, Nele Berthels, Marc Baay, Adrian Wildfire, Volker Oeppling, Sarah M. Fortune, Isabelle Bekeredjian-Ding, Angela van Diepen, Christoph Conrad, Kawsar R. Talaat, Scott Stibitz, Peter G. Kremsner, Wolfram G. Metzger, Karen Brigitta Goetz, Wim Van Molle, Pieter Neels, Stephen J. Thomas, Yves Levy, Daniel F. Hoft, Beno Nyam Yakubu, Andrew Gorringe, Oleg Krut
Publikováno v:
Biologicals. 66:53-61
Controlled human infection models can be helpful to study pathogenesis and immune responses as a basis for the development of vaccines. In controlled human infection models, human challenge agents are used to infect healthy volunteers, therefore, eth
Autor:
Melanie Saville, Bruno Lina, Philippe Duclos, Marc Baay, Philippe Sabot, Joris Vandeputte, Arnaud Marchant, Arnaud Fontanet, Pieter Neels
Publikováno v:
Biologicals
Biologicals, 66
Biologicals, 66
This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-
Autor:
Javier Díez-Domingo, Laurence Torcel-Pagnon, Antonio Carmona, Odile Launay, Gaël Dos Santos, Caterina Rizzo, Mendel Haag, Anke Stuurman, Jos Nauta, Alfredo Vannacci, Simon de Lusignan, Elena Del Rey, Miriam Levi, Bruno Lina, Stefania Bellino, Samantha Nye, Pieter Neels, Hanna Nohynek, Cédric Mahé
Publikováno v:
Expert Review of Vaccines
Expert Review of Vaccines, 2022, 21 (12), pp.1701-1710. ⟨10.1080/14760584.2022.2137144⟩
Expert Review of Vaccines, 2022, 21 (12), pp.1701-1710. ⟨10.1080/14760584.2022.2137144⟩
International audience; Introduction: Fighting pandemics requires an established infrastructure for pandemic preparedness, with existing, sustainable platforms ready to be activated. This includes platforms for disease surveillance, virus circulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6088f0081ce6e036992743c48fbceb
Autor:
Arifa S. Khan, Sebastiaan Theuns, Laurent Mallet, Gwenael Cirefice, Ravneet Bhuller, Ana Goios, Rajinder Suri, Pieter Neels
Publikováno v:
Biologicals. 81:101662
Next Generation Sequencing (NGS) is a new technology that could overcome some of the limitations of the current viral testing methods for demonstrating the absence of adventitious agents in biologics. This report is for the webinar that was organized
Autor:
Ronald Kompier, Pieter Neels, Walter Beyer, Tim Hardman, Dmitry Lioznov, Susanna Kharit, Michail Kostinov
Publikováno v:
F1000Research. 11:259
A systematic review of clinical trials conducted with a low-dose inactivated influenza vaccine adjuvanted by azoximer bromide (AZB, Polyoxidonium), was performed to compare vaccine reactogenicity against non-adjuvant vaccines. We also assessed whethe